Home
Team

Manta Pharma

Manta PharmaManta PharmaManta Pharma
Home
Team
More
  • Home
  • Team

Manta Pharma

Manta PharmaManta PharmaManta Pharma
  • Home
  • Team
Professional man with glasses in suit against blue background.

Dr. Raj S. Davé - Founder, CEO and Chief IP Officer

Dr. Raj S. Davé is Founder, CEO and Chief IP Officer of Manta Pharma, where he leads the development and intellectual property strategy for the company's AI-enabled Active Implantable Medical Device (AIMD) platform. Trained in chemical engineering, materials science and patent law, he combines scientific research experience with nearly three decades of intellectual property practice. He is Founder and President of Davé Law Group and previously led the global pharmaceutical practice at Pillsbury Winthrop Shaw Pittman. Earlier, he conducted polymer and materials research at Monsanto, Bayer and the Michigan Molecular Institute. He holds a D.Sc. in chemical engineering from Washington University, a J.D. from the University of Connecticut and an LL.M. in patent law from George Washington University. His work includes patent prosecution, strategic portfolio development and opinions on patent validity and infringement. 

Man with glasses wearing a beige striped suit and red tie smiling.

Dr. Michael Ross, MD, Co-Founder, Executive Chair of Board

Dr. Michael Ross is Co-Founder and Executive Chair of the Board of Manta Pharma, bringing extensive experience in clinical medicine, pharmaceutical operations and healthcare company leadership. A physician and former healthcare executive, he previously served as President of CPL Inc., the North American division of Cadila Pharmaceuticals, overseeing regional operations, product development and strategic partnerships. He was also Chairman and CEO of Euclid Systems Corporation, a manufacturer of specialty contact lenses, and has served as an Operating Partner at Havencrest Capital Management. Earlier in his career, he practiced obstetrics and gynecology and held academic appointments at George Washington University and Virginia Commonwealth University. He earned his M.D. from George Washington University and his B.S. in biology and chemistry from Dickinson College. At Manta Pharma, he contributes clinical, operational and board-level perspectives to the company's development strategy. 

Dr. Mark Swihart, PhD, Co-Founder, Chief Scientific Advisor

Dr. Mark Swihart is Co-Founder and Chief Scientific Advisor of Manta Pharma and a SUNY Distinguished Professor of Chemical and Biological Engineering at the University at Buffalo. His research focuses on nanoparticle synthesis, nanomaterials processing and functional materials for applications that include biological imaging. His laboratory has advanced methods for producing multicomponent nanoparticles and investigated the chemical processes underlying their formation. These areas of expertise are relevant to the materials and formulation challenges associated with implantable drug delivery. Dr. Swihart is a co-inventor on five issued U.S. patents and has published extensively in chemical engineering and nanomaterials research. He joined the University at Buffalo faculty in 1998, following postdoctoral research at the University of Minnesota. He holds a B.S. in chemical engineering from Rice University and a Ph.D. from the University of Minnesota. 

Dr. Dhaval Shah, PhD, Co-Founder, Chief Pharmaceutical Science Advisor

Dr. Dhaval Shah is Co-Founder and Chief Pharmaceutical Science Advisor of Manta Pharma and Professor of Pharmaceutical Sciences at the University at Buffalo. His research focuses on pharmacokinetics, pharmacodynamics and quantitative modeling of drug exposure and response, with particular expertise in biologics and antibody-drug conjugates. Before entering academia, he served as a Principal Scientist at Pfizer. His laboratory has developed models supporting drug development, tumor growth prediction and pediatric dose selection. At Manta Pharma, his scientific expertise informs the evaluation of drug delivery and dosing strategies for the company's AI-enabled implantable platform. Dr. Shah earned his Ph.D. from the University at Buffalo, his master's degree from the National Institute of Pharmaceutical Education and Research and his bachelor's degree from Gujarat University. He received the 2020 North American New Investigator Award from the International Society for the Study of Xenobiotics. 

Dr. Ryan Sochol, PhD, Co-Founder, Chief Technology Advisor

Dr. Ryan Sochol is Co-Founder and Chief Technology Advisor of Manta Pharma and an Associate Professor at the University of Maryland, College Park, where he directs the Maryland Robotics Center. He leads the Bioinspired Advanced Manufacturing Laboratory, which develops micro- and nanoscale 3D-printing technologies for biomedical applications. His research encompasses microfluidics, precision microfabrication and complex microsystems, expertise relevant to the engineering of Manta Pharma's implantable drug delivery platform and intelligent micro-pump. He is a fellow of the Robert E. Fischell Institute for Biomedical Devices and holds academic appointments across mechanical engineering and systems research. Dr. Sochol completed postdoctoral research through the Harvard-MIT Division of Health Sciences and Technology and at the University of Tokyo. He earned his B.S. from Northwestern University and his M.S. and Ph.D. from the University of California, Berkeley. 

Mr. David Fox, JD, Co-Founder, Chief Strategy Advisor

Mr. David Fox is Co-Founder and Chief Strategy Advisor of Manta Pharma and leads the Pharmaceuticals and Biotechnology Regulatory Practice at Hogan Lovells. A former senior attorney at the U.S. Food and Drug Administration, he advises pharmaceutical and biotechnology companies on regulatory strategy, product development and complex transactions. His work covers prescription drugs, biologics, combination products and controlled substances, including matters involving FDA review, market exclusivity and patent-related regulatory issues. He also advises companies on assessing the value and regulatory risks of life-sciences assets. His experience provides a regulatory and commercial perspective as Manta Pharma advances its implantable drug delivery platform toward development and potential market entry. Mr. Fox holds a J.D. from New York University School of Law and a B.A. from the College of William & Mary. 

Mr. Sampath Ramaswami, COO

Mr. Sampath Ramaswami is Chief Operating Officer of Manta Pharma, bringing decades of experience in technology strategy, product development and enterprise operations. He has held senior leadership roles at Hughes, including Vice President of Strategy and Senior Director of Product Management, with responsibility for market opportunities, new service development and product roadmaps. He previously served as Senior Director of Strategic Marketing at Hughes Network Systems Europe and held product development and planning roles at AT&T Paradyne and AT&T Bell Laboratories. His background encompasses translating technical capabilities into commercially viable services, coordinating cross-functional teams and evaluating emerging technologies. At Manta Pharma, he brings this operational perspective to planning and execution for an emerging medical-device platform. He earned a B.S. in Electrical Engineering and Computer Science in 1985 and an M.S. in Electrical Engineering, concentrating in Communications, in 1987. 

Dr. Ruben Acevedo, PhD, CTO

Dr. Ruben Acevedo is Chief Technology Officer of Manta Pharma, with expertise in mechanical engineering, microscale fabrication and technologies for controlled drug delivery. He earned his Ph.D. in mechanical engineering from the University of Maryland, College Park, where he conducted research in the Bioinspired Advanced Manufacturing Laboratory. His work includes 3D-nanoprinted microcapsules, microfluidic structures and precision manufacturing techniques with potential biomedical applications. He received an Outstanding Student Paper Award at the 2021 IEEE MEMS conference for research on 3D nanoprinting. He earned his B.S. in mechanical engineering from the University of California, Los Angeles, and his M.S. from the University of Maryland. His professional background also includes consulting experience at Boston Consulting Group. At Manta Pharma, he contributes technical expertise to development of the company's implantable drug delivery system. 

Smiling woman in a bright yellow blazer against a black background.

Ami (Patel) Shah - Independent Director

Ami (Patel) Shah is an Independent Director of Manta Pharma and an intellectual property investor and attorney whose work spans technology finance, patent licensing and corporate strategy. She is Co-Founder and CEO of LevelSet Bio and has served as a Managing Director at Fortress Investment Group, evaluating investment opportunities secured by intellectual property. Previously, she led Intel's Global Wireless Patents organization, overseeing patent procurement, licensing, transactions and monetization. She began her legal career as an examiner at the U.S. Patent and Trademark Office and later practiced at Fish & Richardson and Dorsey & Whitney. Her experience in IP-backed financing and commercialization contributes to Manta Pharma's strategic oversight as it develops and protects its implantable technology platform. She holds a B.S. in Electrical and Computer Engineering from Wayne State University and a J.D. from Cleveland State University. 

Smiling woman with glasses indoors, wearing a patterned turtleneck and black vest.

Aparna Dave - Independent Director

Aparna Dave is an Independent Director of Manta Pharma and an attorney with extensive experience advising businesses and individuals on U.S. immigration law. She leads the Law Office of Aparna Davé, where her practice includes employment-based immigration, permanent residence, citizenship and nonimmigrant visa matters. She has represented employers, research professionals, university faculty and students, addressing the immigration requirements that affect international recruitment and professional mobility. Her legal background brings an additional perspective to Manta Pharma's board on organizational matters and cross-border talent considerations. She earned her J.D. from Boston University School of Law in 1992 and completed undergraduate studies in sociology at Saginaw Valley State University and economics at the University of Calcutta. During her legal education, she worked with Harvard Law School's Immigration Clinic. She is a member of the American Immigration Lawyers Association. 

Man with glasses wearing a suit and tie, smiling.

Dr. Ravi Subrahmanyan - Technical Advisor

Dr. Ravi Subrahmanyan is Technical Advisor to Manta Pharma, bringing expertise in materials engineering, medical electronics and the reliability of implantable devices. He previously served as Executive Director of Advanced Technologies at Micro Systems Engineering, leading work on materials selection, manufacturing processes and design technologies for high-reliability medical microelectronics. Earlier, he held engineering and management roles at Motorola. His published technical work examines component reliability and testing methods for medical electronic systems, including flexible printed circuit boards used in implantable devices. This experience is relevant to evaluating materials, manufacturing quality and long-term reliability requirements for Manta Pharma's implantable drug delivery technology. He earned a B.Tech. in metallurgical engineering from the Indian Institute of Technology in 1985 and an M.S. and Ph.D. in materials science from Cornell University in 1988 and 1990, respectively. 

Contact Us

Office Address: 107 Alderwood Drive

Gaithersburg, MD 20878, USA

Laboratory Address: University at Buffalo Technology Incubator at Baird Research Park,
Suite 223
1576 Sweet Home Road, Amherst, NY 14228


Email: raj.dave@mantapharma.com

US phone: (240) 715-2061

Manta Pharma LLC is incorporated in Maryland and registered in the New York State.


Copyright © 2026 Manta Pharma - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept